SCHEMBL22158273

SCHEMBL22158273

N#Cc1cc(-n2c3ccccc3c3ccc(-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)cc32)c(-c2cc(F)cc(F)c2)cc1-n1c2ccccc2c2ccc(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)cc21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SSTR2 P30874 1/20 0.35
CYP11B1 P15538 2/20 0.33
CYP11B2 P19099 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
HIF1A Q16665 1/20 0.33
SQOR Q9Y6N5 1/20 0.33
ABCG2 Q9UNQ0 2/20 0.32
NR3C1 P04150 1/20 0.32
ALDH1A1 P00352 3/20 0.32
LMNA P02545 3/20 0.32
CYP1A2 P05177 3/20 0.32
MEN1 O00255 2/20 0.32
TSHR P16473 2/20 0.32
KMT2A Q03164 2/20 0.32
HSD17B10 Q99714 2/20 0.32
CYP2C9 P11712 2/20 0.32
CYP2C19 P33261 2/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CLK4 Q9HAZ1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22158275 0.98 SSTR2 (0.36) SSTR2CYP11B1CYP11B2SMN1; SMN2HIF1A
SCHEMBL22158274 0.94 SSTR2 (0.36) SSTR2CYP11B1CYP11B2SQORABCG2
SCHEMBL22156817 0.94 SSTR2 (0.35) SSTR2CYP11B1CYP11B2SMN1; SMN2SQOR
SCHEMBL22156564 0.91 CYP11B1 (0.36) SSTR2CYP11B1CYP11B2SMN1; SMN2HIF1A
SCHEMBL22158277 0.90 SSTR2 (0.35) SSTR2CYP11B1CYP11B2SQORNR3C1
SCHEMBL22156563 0.89 CYP11B1 (0.37) SSTR2CYP11B1CYP11B2SMN1; SMN2HIF1A
SCHEMBL22156416 0.88 CYP11B1 (0.40) SSTR2CYP11B1CYP11B2SMN1; SMN2HIF1A
SCHEMBL19913263 0.88 ABCG2 (0.38) SMN1; SMN2HIF1AABCG2ALDH1A1LMNA
SCHEMBL22156815 0.88 SSTR2 (0.36) SSTR2CYP11B1CYP11B2SQORABCG2
SCHEMBL19917958 0.87 ABCG2 (0.33) SMN1; SMN2HIF1AABCG2ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200203628-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2020-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200203628-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, ORC3, OR51E2 SSTR2 911/4885CYP11B1 827/4885CYP11B2 531/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.